Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1979-04 to 1979-05
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Remarks:
no negative control group; instead positive control group (20 animals tested positive with 50.000 IU/100 g of Penicillin-G-Na); maximum non-irritating concentrations used for induction instead of highest to cause mild-to-moderate skin irritation; no details on animals and environmental conditions, no details on erythema and edema of individual animals

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1979
Report date:
1979

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
adopted 17 Jul 1992
Deviations:
yes
Remarks:
no negative control group but positive control group (50.000 IU/100 g of Penicillin-G-Na); maximum non-irritating concentrations used for induction instead of highest to cause mild-to-moderate skin irritation; topical induction for 24 h instead of 48 h
GLP compliance:
no
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
The test was performed in 1979 before the alternative OECD guidelines (LLNA and in vitro test methods) were available.

Test material

Constituent 1
Chemical structure
Reference substance name:
3-(methylthio)propionaldehyde
EC Number:
221-882-5
EC Name:
3-(methylthio)propionaldehyde
Cas Number:
3268-49-3
Molecular formula:
C4H8OS
IUPAC Name:
3-(methylthio)propionaldehyde

In vivo test system

Test animals

Species:
guinea pig
Strain:
Pirbright-Hartley
Sex:
male
Details on test animals and environmental conditions:
- Source: Tierzüchterei Willy Krispien, Ahrensburg, Germany
- Animal body weight at study initiation: 300 - 320 g
- no data on housing, diet, water supply and environmental conditions

Study design: in vivo (non-LLNA)

Induction
Route:
intradermal and epicutaneous
Vehicle:
physiological saline
Concentration / amount:
intradermal induction on Day 1: 1%
epicutaneous induction on Day 7: 5%
Day(s)/duration:
intradermal induction: single treatment; epicutaneous induction: 24 h
Adequacy of induction:
other: Selection of concentration based on the results of the pre-test (determination of maximum non-irritating concentrations)
Challenge
No.:
#1
Route:
epicutaneous, occlusive
Vehicle:
unchanged (no vehicle)
Concentration / amount:
5% in physiological saline
Day(s)/duration:
24 h
Adequacy of challenge:
highest non-irritant concentration
No. of animals per dose:
20
Details on study design:
RANGE FINDING TESTS:
The primary irritation by the test substance upon intracutaneous and epicutaneous exposure was tested in a pre-experiment. Graded dilutions of the test substance in physiological saline (2-fold dilution steps) were applied. The animals were induced with 0.1 mL test substance intradermally, followed by epicutaneous induction of 1 mL test substance one week later under occlusive conditions. Intracutaneous doses were tested in 5 animals each; each animal received up to 5 different concentrations. Epicutaneous doses were tested in 5 animals, each; but only one concentration per animal. Skin reactions were evaluated 24 h post application. Concentrations for the main experiment were chosen to be the highest non-irritating concentration.

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and epicutaneous, respectively)
- Exposure period: single injection (intradermal) and 48 h (epicutaneous)
- Test groups:
Intradermal (3 pairs of injections):
Injection 1: 1:1 (v/v) mixture complete Freund's adjuvant (FCA) and distilled water
Injection 2: 1% test substance in phosphate buffered saline (PBS)
Injection 3: 1% test substance in a 1:1 mixture of complete Freund's adjuvant (FCA) and PBS
Epicutaneous: One week after the injections, a 2 x 4 cm patch of gauze was soaked with 5% test item formulated in PBS and applied to the test site. The treated areas were covered with alufoil and fixed with an elastic bandage for 24 h.
- Control group: Not included in the study.

B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day of challenge: 2 weeks after epidermal induction (Day 20)
- Exposure period: 24 h
- Test groups: test substance
- Concentrations: 5% formulation in PBS
- Evaluation (hr after challenge): 48 h
Challenge controls:
Not included in the study.
Positive control substance(s):
yes
Remarks:
Penicillin-G-Na

Results and discussion

Positive control results:
All animals induced intracutaneously, epicutaneously and challenged with 50.000 IU / 100 g of Penicillin-G-Na tested positive in this study.

In vivo (non-LLNA)

Resultsopen allclose all
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
induction: 1% intradermal, 5% epicutaneous; challenge 5%
No. with + reactions:
20
Total no. in group:
20
Clinical observations:
no
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
positive control
Dose level:
induction: 50.000 IU / 100 g intradermal, 50.000 IU / 100 g epicutaneous; challenge 550.000 IU / 100 g
No. with + reactions:
20
Total no. in group:
20
Clinical observations:
no
Reading:
2nd reading
Group:
negative control
Remarks on result:
other: No negative control included in this study.

Any other information on results incl. tables

No mortality or adverse clinical observations were reported in this study. In addition, the result of the first reading time point after challenge were not reported.

Applicant's summary and conclusion

Interpretation of results:
Category 1A (indication of significant skin sensitising potential) based on GHS criteria
Conclusions:
CLP: Skin sens. 1, H317 according to Regulation (EC) No. 1272/2008

Categories Display